Viewing Study NCT01894061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 AM
Ignite Modification Date: 2026-05-17 @ 7:39 PM
Study NCT ID: NCT01894061
Status: COMPLETED
Last Update Posted: 2025-02-17
First Post: 2013-07-03
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Sponsor: Case Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Giant Cell Glioblastoma View
None Adult Glioblastoma View
None Adult Gliosarcoma View
None Recurrent Adult Brain Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult giant cell glioblastoma View
None adult glioblastoma View
None adult gliosarcoma View
None recurrent adult brain tumor View
None Bevacizumab-naive View
None NovoTTF-100A View